(ISVL) International Developed - Overview
Etf: Small-Cap, Value, International, Developed, Equities
Dividends
| Dividend Yield | 2.93% |
| Yield on Cost 5y | 4.39% |
| Yield CAGR 5y | 5.87% |
| Payout Consistency | 98.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.9% |
| Relative Tail Risk | -0.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.23 |
| Alpha | 37.44 |
| Character TTM | |
|---|---|
| Beta | 0.638 |
| Beta Downside | 0.635 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.93% |
| CAGR/Max DD | 1.67 |
Description: ISVL International Developed December 30, 2025
The iShares International Developed Small-Cap Value Factor ETF (BATS: ISVL) seeks to track a proprietary index that targets undervalued small-cap stocks in developed markets. At least 80 % of the portfolio must be invested in the index’s component securities or securities that are “substantially identical,” while up to 20 % may be allocated to futures, options, swaps, cash, or other securities that the manager believes will improve tracking error. Because the fund’s holdings are concentrated in a relatively narrow segment of the market, it is classified as non-diversified under SEC rules.
Key quantitative metrics (as of the most recent filing) include an expense ratio of 0.30 %, assets under management of roughly $300 million, and an average weighted market-cap of about $2.5 billion per holding. The fund’s top sector exposures are financials (≈ 30 %), industrials (≈ 20 %), and consumer discretionary (≈ 15 %). Its dividend yield hovers near 2.5 % and the fund’s beta relative to the MSCI World Index is modest (~0.8), reflecting the lower volatility typical of small-cap value stocks.
Performance drivers to watch are global small-cap equity sentiment, the relative value gap between growth and value styles, and currency fluctuations (most holdings are priced in euros, pounds, and yen). A tightening monetary environment can compress valuations for small-cap firms, while a weaker USD may boost the fund’s foreign-currency-adjusted returns.
For a deeper quantitative breakdown of ISVL’s factor exposure, you might explore the ValueRay platform.
What is the price of ISVL shares?
Over the past week, the price has changed by +1.60%, over one month by +6.40%, over three months by +17.51% and over the past year by +48.18%.
Is ISVL a buy, sell or hold?
What are the forecasts/targets for the ISVL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 63.8 | 23.8% |
ISVL Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 111.2m USD (111.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 111.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 111.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.27% (E(111.2m)/V(111.2m) * Re(8.27%) + (debt-free company))
Discount Rate = 8.27% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)